Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3172
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited